, 2022-06-23 21:03:24,
Sophia Majeed, principal clinical scientist and project team lead in the 23andMe Therapeutics group, knows how volatile and potentially controversial the biotechnology field is. The company, which has 579 employees, has been through a couple of contentious rounds with the FDA over whether its products are safe “medical devices.” There’s also the ethical question of what 23andMe does with the data it’s collected from people after they’ve received their DNA results.
For Majeed, the workplace has to be a safe and secure environment. “23andMe workplace culture encourages people to speak out and be their authentic selves,” Majeed said. “Our CEO, Anne Wojcicki, sets the tone by encouraging people to have difficult conversations, and she doesn’t shy away from responding to tough questions.”
To read the original article, go to Click here